Phagocytosis of apoptotic cells and the resolution of inflammation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1639, Issue 3, 2003, Pages 141-151

  Maderna, Paola ^b   Godson, Catherine ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NONE

Author keywords

Apoptotic cell; Phagocytosis; Resolution of inflammation

Indexed keywords

CD31 ANTIGEN; DEXAMETHASONE; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 3; LIPOXIN A; PHOSPHATIDYLSERINE; SCAVENGER RECEPTOR; SUGAR;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL SURFACE; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; INFLAMMATION; LEUKOCYTE; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0242577378     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2003.09.004     Document Type: Review

References (119)

1. Metchnikoff E. Sur la lutte des cellules de l'organisme contre l'invasion des microbes. Ann. Inst. Pasteur. 1:1887;321-345.
2. Savill J., Dransfield I., Gregory C., Haslett C.A. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev., Immunol. 12:2002;965-975.
3. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784-788.
4. Henson P.M., Bratton D.L., Fadok V.A. Apoptotic cell removal. Curr. Biol. 11:2001;R795-R805.
5. Hughes J., Liu Y., Van Damme J., Savill J. Human glomerular mesangial cell phagocytosis of apoptotic cells is mediated by a CD36-independent vitronectin receptor/thrombospondin recognition mechanism. J. Immunol. 158:1997;4389-4397.
6. Savill J., Smith J., Sarraf C., Ren Y., Abbott F., Rees A. Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int. 42:1992;924-936.
7. Ren Y., Savill J. Apoptosis: the importance of being eaten. Cell Death Differ. 5:1998;563-568.
8. Manfredi A.A., Iannacone M., D'Auria F., Rovere-Querini P. The disposal of dying cells in living tissues. Apoptosis. 7:2002;153-161.
9. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 390:1997;350-351.
10. 2 and PAF. J. Clin. Invest. 101:1998;890-898.
11. Huynh M.L.N., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promoted TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109:2002;41-50.
12. Williamson P., Schlegel R.A. Transbilayer phospholipid movement and the clearance of apoptoic cells. Biochim. Biophys. Acta. 1585:2002;53-63.
13. May R.C., Machesky L.M. Phagocytosis and the actin cytoskeleton. J. Cell Sci. 114:2000;1061-1077.
14. Fadok V.A., Bratton D., Courtney Frasch L., Warner M.L., Henson P.M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5:1998;551-562.
15. Fadok V.A., de Cathelineau A., Daleke D.L., Henson P.M., Bratton D.L. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 276:2001;1071-1077.
16. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 405:2000;85-90.
17. Fadok V.A., Bratton D.L., Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake and consequences. J. Clin. Invest. 108:2001;957-962.
18. Verhoven B., Schlegel R.A., Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182:1995;1597-1601.
19. Frasch S.C., Henson P.M., Kailey J.M., Richter D.A., Janes M.S., Fadok V.A., Bratton D.L. Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cδ J. Biol. Chem. 275:2000;23065-23073.
20. Hamon Y., Broccardo C., Chambenoit O., Luciani M.F., Toti F., Chaslin S., Freysinet J.M., Devaux P.F., McNeish J., Marguet D., Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2:2000;399-406.
21. Marguet D., Luciani M.F., Moynault A., Williamson P., Chimini G. Engulfment of apoptotic cells involves the redistribution of membrane phosphatidlyserine on phagocyte and prey. Nat. Cell Biol. 1:1999;454-456.
22. Callahan M.K., Williamson P., Schegel R.A. Surface expression of phosphatidlyserine is a general feature in the pathogenesis of apoptotic lymphocytes by macrophages. Cell Death Differ. 7:2000;645-653.
23. Balasubramanian K., Chandra J., Schroit A.J. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of β2-glycoprotein I in macrophage recognition. J. Biol. Chem. 272:1997;31113-31117.
24. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature. 417:2002;182-187.
25. Nakano T., Ishimoto Y., Kishino J., Umeda M., Inoue K., Nagata K., Ohashi K., Mizuno K., Arita H. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J. Biol. Chem. 272:1997;29411-29414.
26. Anderson H.A., Maylock C.A., Williams J.A., Paweletz C.P., Shu H., Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 4:2003;87-91.
27. Anderson H.A., Englert R., Gursel I., Shacter E. Oxidative stress inhibits the phagocytosis of apoptotic cells that have externalised phosphatidylserine. Cell Death Differ. 9:2002;616-625.
28. Duvall E., Wyllie A.H., Morris R.G. Macrophage recognition of cells undergoing programmed cell death. Immunology. 56:1985;351-358.
29. Dini L., Autuori F., Lentini A., Oliverio S., Piacentini M. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett. 296:1992;174-178.
30. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., Henson P.M. C1q and mannose-binding lectin engagement of cell-surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:2001;781-795.
31. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells. J. Exp. Med. 192:2000;359-366.
32. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:1998;56-59.
33. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158:1997;4525-4528.
34. Eggleton P., Tenner A.J., Reid K.B. C1q receptors. Clin. Exp. Immunol. 120:2000;406-412.
35. Basu S., Binder R.J., Ramalingam T., Srivastava P.K. CD91 is a common receptor for heat-shock proteins pg96, hsp70 and calreticulin. Immunity. 14:2001;303-313.
36. Moffatt O.D., Dewitt A., Bell E.D., Simmons D.L., Gregory C.D. Macrophage recognition of ICAM-3 on apoptotic leukocytes. J. Immunol. 162:1999;6800-6810.
37. Gregory C.D. CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr. Opin. Immunol. 12:2000;27-34.
38. Platt N., Suzuki H., Kurihara Y., Kodama T., Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12456-12460.
39. Savill J., Hogg N., Ren Y., Haslett C. Thrombospondin co-operates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1992;1513-1522.
40. Oka K., Sawamura T., Kikuta K., Itokawa S., Kume N., Kita T., Masaki T. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9535-9540.
41. Ren Y., Silverstein R.L., Allen J., Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181:1995;1857-1862.
42. Brown M.S., Goldstein J.L. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 343:1990;508-519.
43. Savill J., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today. 14:1993;131-136.
44. Fadok V.A., Warner M.L., Bratton D.L., Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161:1998;6250-6257.
45. Ryeom S.W., Sparrow J.R., Silverstein R.L. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J. Cell Sci., Suppl. 109:1996;387-395.
46. Husemann J., Loike J.D., Anankov R., Febbraio M., Silverstein S.C. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia. 40:2002;195-205.
47. Husemann J., Silverstein S.C. Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain. Am. J. Pathol. 158:2001;825-832.
48. Platt N., Suzuki H., Kodama T., Gordon S. Apoptotic thymocyte clearance in scavenger receptor class A-deficient mice is apparently normal. J. Immunol. 164:2000;4861-4867.
49. Franc N.C., Heitzler P., Ezekowitz R.A., White K. Requirement for croquemort in phagocytosis of apoptotic cells in Drosophilia. Science. 284:1999;1991-1994.
50. Brown S., Heinisch I., Ross E., Shaw K., Buckley C.D., Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 418:2002;200-203.
51. Griffin F.M. Jr., Griffin J.A., Leider J.E., Silverstein S.C. Studies on the mechanism of phagocytosis: I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma-membrane. J. Exp. Med. 142:1975;1263-1282.
52. Allen L.A., Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J. Exp. Med. 184:1996;627-637.
53. Swanson J.A., Baer S.C. Phagocytosis by zippers and triggers. Trends Cell Biol. 5:1995;89-93.
54. Henson P.M., Bratton D.L., Fadok V.A. The phosphatidylserine receptor: a crucial molecular switch? Nat. Rev., Mol. Cell Biol. 2:2001;627-633.
55. Somersan S., Bhardwaj N. Tethering and tickling: a new role for the phosphatidylserine receptor. J. Cell. Biol. 155:2001;501-504.
56. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature. 420:2002;629-635.
57. Cox D., Chang P., Zhang Q., Reddy P.G., Bokoch G.M., Greenberg S. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J. Exp. Med. 186:1997;1487-1494.
58. Caron E., Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science. 282:1998;1717-1721.
59. Castellano F., Montcourrier P., Chavrier P. Membrane recruitment of Rac1 triggers phagocytosis. J. Cell. Sci. 113:2000;2955-2961.
60. May R.C., Caron E., Hall A., Machesky L.M. Involvement of the Arp2/3 complex in phagocytosis mediated by FcγR or CR3. Nat. Cell Biol. 2:2000;246-248.
61. Parnaik R., Raff M.C., Scholes J. Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr. Biol. 10:2000;857-860.
62. Leverrier Y., Ridley A.J. Requirement for Rho GTPases and PI 3-kinases during apoptotic cell phagocytosis by macrophages. Curr. Biol. 11:2001;195-199.
63. Leverrier Y., Lorenzi R., Blundell M.P., Brickell P., Kinnon C., Ridley A.J., Thrasher A.J. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J. Immunol. 166:2001;4831-4834.
64. 5 integrin recruits the CrkII/Dock180/Rac1 molecular complex for phagocytosis of apoptotic cells. Nat. Cell Biol. 2:2000;899-905.
65. Wu Y.C., Horvitz H.R. C. elegans phagocytosis cell-migration protein CED-5 is similar to human DOCK180. Nature. 392:1998;501-504.
66. Reddien P.W., Horvitz H.R. CED-2/Crkll and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. Nat. Cell Biol. 2:2000;131-136.
67. Gumienny T.L., Brugnera E., Tosello-Trampont A.C., Kinchen J.M., Haney L.B., Nishiwaki K., Walk S.F., Nemergut M.E., Macara I.G., Francis R., Schedl T., Qin Y., Van Aelst L., Hengartner M.O., Ravichandran K.S. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell. 107:2001;27-41.
68. Ellis R.E., Jacobson D.M., Horvitz H.R. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. Genetics. 129:1991;79-94.
69. Chung S., Gumienny T.L., Hengartner M.O., Driscoll M.A. A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nat. Cell Biol. 2:2000;931-937.
70. Zhou Z., Hartwieg E., Horvitz H.R. CED-1 is a transmembrane receptor that mediates cell corpse engulfment in C. elegans. Cell. 104:2001;43-56.
71. Liu Q.A., Hengartner M.O. Human CED-6 encodes a functional homologue of the Caenorhabditis elegans engulfment protein CED-6. Curr. Biol. 9:1999;1347-1350.
72. Wu Y.C., Horvitz H.R. The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters. Cell. 93:1998;951-960.
73. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class-I-restricted CTLs. Nature. 392:1998;86-89.
74. Urban B.C., Willcox N., Roberts D.J. A role for CD36 in the regulation of dendritic-cell function. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8750-8755.
75. Stuart L.M., Lucas M., Simpson C., Lamb J., Savill J., Lacy-Hulbert A. Inhibitory effects of apoptotic-cell ingestion upon endotoxin-driven myeloid dendritic-cell maturation. J. Immunol. 168:2002;1627-1635.
76. Bellone M., Iezzi G., Rovere P., Galati G., Ronchetti A., Protti M.P., Davoust J., Rugarli C., Manfredi A.A. Processing of engulfed apoptotic bodies yields T-cell epitopes. J. Immunol. 159:1997;5391-5399.
77. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1998;1359-1368.
78. Casciola-Rosen L., Andrade F., Ulanet D., Wong W.B., Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190:1999;815-826.
79. Banchereau J., Schuler-Thurner B., Palucka A.K., Schuler G. Dendritic cells as vectors for therapy. Cell. 106:2001;271-274.
80. Goulding N.J., Guyre P.M. Glucocorticoids, lipocortins and the immune response. Curr. Opin. Immunol. 5:1993;508-513.
81. Liu Y., Cousin J.M., Hughes J., Van Damme J., Seckl J.R., Haslett C., Dransfield I., Savill J., Rossi A.G. Glucocorticoids promote non-phlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162:1999;3639-3646.
82. Giles K.M., Ross K., Rossi A.G., Hotchin N.A., Haslett C., Dransfield I. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation and high levels of active Rac. J. Immunol. 167:2001;976-986.
83. Serhan C.N. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins. 53:1997;107-137.
84. Brady H.R., Serhan C.N. Potential vascular roles for lipoxins in the "stop programs" of host defense and inflammation. Trends Cardiovasc. Med. 5:1995;186-192.
85. McMahon B., Mitchell S., Brady H.R., Godson C. Lipoxins: revelations on resolution. Trends Pharmacol. Sci. 22:2001;391-395.
86. Serhan C.N. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat. 69:2002;433-455.
87. Claria J., Serhan C.N. Aspirin triggers novel bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9475-9479.
88. 4 inhibit tumor necrosis factor α-induced neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J. Exp. Med. 189:1999;1923-1930.
89. 4 modulates transmigration of human neutrophils across intestinal epithelial cell monolayers. J. Clin. Invest. 92:1993;75-82.
90. 4 and N-formyl-L-methionyl-L- leucyl-L-phenylalanine. Clin. Sci. (London). 77:1989;195-203.
91. Papayianni A., Serhan C.N., Brady H.R. Lipoxins inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156:1996;2264-2272.
92. Schottelius A.J., Giesen C., Asadullah K., Fierro I.M., Colgan S.P., Bauman J., Guilford W., Perez H.D., Parkinson J.F. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. J. Immunol. 169:2002;7063-7070.
93. 4-induced inflammation in the hamster cheek pouch. Acta Physiol. Scand. 137:1989;571-572.
94. Clish C.B., O'Brien J.A., Gronert K., Stahl G.L., Petasis N.A., Serhan C.N. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8247.s-8252.s.
95. 4 stable analogues. J. Clin. Invest. 101:1998;819-826.
96. 4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164:2000;2660-2666.
97. Goh J., Baird A.W., O'Keane C., Watson R.W., Cottell D., Bernasconi G., Petasis N.A., Godson C., Brady H.R., MacMathuna P. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. J. Immunol. 167:2001;2772-2780.
98. Chiang N., Fierro I.M., Gronert K., Serhan C.N. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:2000;1197-1207.
99. Yingying L., Yazawa H., Gong W., Yu Z., Ferrans V.J., Murphy P.M., Ming J. Cutting edge: the neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein coupled receptor formyl peptide receptor-like 1. J. Immunol. 166:2001;1448-1451.
100. Su S.B., Gong W., Gao J.L., Shen W., Dunlop N.M., Murphy P.M., Oppenheim J.J., Wang J.M. A seven-transmembrane, G-protein coupled receptor, FPRL1 mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:1999;395-402.
101. 4 receptor. Nat. Med. 8:2002;1296-1302.
102. Arur S., Uche E.U., Rezaul K., Fong M., Scranton V., Cowan A.E., Mohler W., Han D.K. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell. 4:2003;587-598.
103. 4 receptor. J. Biol. Chem. 272:1997;6972-6978.
104. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183:1996;137-146.
105. Godson C., Mitchell S., Harvey K., Petasis N.A., Hogg N., Brady H.R. Cutting edge: lipoxins rapidly stimulate non-phlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164:2000;1663-1667.
106. Mitchell S., Thomas G., Harvey K., Cottell D., Reville K., Berlasconi G., Petasis N.A., Erwig L., Rees A.J., Savill J., Brady H.R., Godson C. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 13:2002;2497-2507.
107. Maderna P., Cottell D.C., Berlasconi G., Petasis N.A., Brady H.R., Godson C. Lipoxins induce actin reorganisation in monocytes and macrophages, but not in neutrophils: differential involvement of Rho GTPases. Am. J. Pathol. 160:2002;2275-2283.
108. Lauber K., Bohn E., Kröber S.M., Xiao Y., Blumenthal S.G., Lindemann R.K., Marini P., Wiedig C., Zobywalski A., Baksh S., Xu Y., Autenrieth I.B., Schulze-Osthoff K., Belka C., Stuhler G., Wesselborg S. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 113:2003;717-730.
109. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 411:2001;207-211.
110. Walport M.J., Lachmann P.J. Complement deficiencies and abnormalities of the complement system in systemic lupus erythematosus and related disorders. Curr. Opin. Rheumatol. 2:1990;661-663.
111. Casciola-Rosen L., Rosen A., Petri M., Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 93:1996;1624-1629.
112. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic-cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41:1998;1241-1250.
113. Gal A., Li Y., Thompson D.A., Weir J., Orth U., Jacobson S.G., Apfelstedt-Sylla E., Vollrath D. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat. Genet. 26:2000;270-271.
114. Camenisch T.D., Koller B.H., Earp H.S., Matsushima G.K. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide- induced endotoxic shock. J. Immunol. 162:1999;3498-3503.
115. Doring G. The role of neutrophil elastase in chronic inflammation. Am. J. Respir. Crit. Care Med. 150:1994;S114-S117.
116. Vandivier R.W., Fadok V.A., Hoffmann P.R., Bratton D.L., Penvari C., Brown K.K., Brain J.D., Accurso F.J., Henson P.M. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J. Clin. Invest. 109:2002;661-670.
117. Bell M.D., Lopez-Gonzalez R., Lawson L., Hughes D., Fraser I., Gordon S., Perry V.H. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J. Neurocytol. 23:1994;605-613.
118. Christie R.H., Freeman M., Hyman B.T. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am. J. Pathol. 148:1996;399-403.
119. van Lent P.L., Licht R., Dijkman H., Holthuysen A.E., Berden J.H., van den Berg W.B. Uptake of apoptotic leukocytes by synovial lining macrophages inhibits immune complex-mediated arthritis. J. Leukoc. Biol. 70:2001;708-714.